Orion Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-100
Closed -$2.06K – 461
2024
Q1
$2.06K Hold
100
– – ﹤0.01% 461
2023
Q4
$2.71K Hold
100
– – ﹤0.01% 456
2023
Q3
$2.96K Buy
+100
New +$3.52K ﹤0.01% 440
2023
Q2
– Sell
-100
Closed -$2.34K – 259
2023
Q1
$2.34K Hold
100
– – ﹤0.01% 428
2022
Q4
$2.72K Hold
100
– – ﹤0.01% 369
2022
Q3
$5K Hold
100
– – ﹤0.01% 353
2022
Q2
$4K Hold
100
– – ﹤0.01% 376
2022
Q1
$7K Hold
100
– – ﹤0.01% 349
2021
Q4
$10K Hold
100
– – 0.01% 306
2021
Q3
$13K Hold
100
– – 0.01% 279
2021
Q2
$12K Hold
100
– – 0.01% 257
2021
Q1
$15K Hold
100
– – 0.01% 234
2020
Q4
$13K Buy
+100
New +$11.5K 0.01% 234

Other funds holding GH

Orion Capital Management's GH Position: Q2 2024 in Review

Orion Capital Management sold out of Guardant Health (GH) in Q2 2024, closing a stake of 100 shares — an estimated $2.06K sold.

Orion Capital Management first reported a position in GH in Q4 2020 and held it in 13 quarters. The position peaked at $15K in Q1 2021. 282 funds tracked by Wall St. Rank hold GH as of Q2 2024.

  • Orion Capital Management reported no remaining Guardant Health position as of Q2 2024 after selling out during the quarter.
  • Orion Capital Management sold 100 Guardant Health shares in Q2 2024, an estimated $2.06K.
  • Orion Capital Management first reported a position in Guardant Health in Q4 2020 and held it in 13 quarters.
  • Orion Capital Management's Guardant Health position peaked at $15K in Q1 2021.
  • 282 funds tracked by Wall St. Rank held Guardant Health as of Q2 2024.

Based on Orion Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.